Here are five quick facts:
1. NuVasive has underperformed the index by 5.65 percent in the last four weeks.
2. The shares presently have a recommended consensus of “buy.”
3. The shares registered a one year high of $51.25 on May 29, 2015. On July 18, 2014, the shares had a one-year low of $32.39.
4. The 50-day moving average is $48.8 and the 200-day moving average is $46.67.
5. On Friday, the shares opened for trading at $46.64 and hit $46.96. The shares ended the session at $46.77.
More articles on devices:
Medtronic gives $1.1M in health access grants for underserved communities — 5 key notes
5 key thoughts on K2M: Is an acquisition in the future?
America responds to FDA questions on spinal device: 5 key notes
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.